Table 3.
Imaging findings of the 35 ALVC female patients.
| Overall n = 35 |
Childbearing Women n = 16 |
Nulliparous Women n = 19 |
p | |
| Echocardiographic findings | ||||
| LVEDVi (mL/m2) | 76 ± 15 | 80 ± 15 | 73 ± 15 | 0.104 |
| LVESVi (mL/m2) | 39 ± 13 | 42 ± 12 | 36 ± 12 | 0.088 |
| LVEF (%) | 50 ± 7 | 48 ± 7 | 52 ± 7 | 0.230 |
| LV kinetic abnormalities | 17 (49%) | 8 (50%) | 9 (47%) | 0.370 |
| RVA (cm2) | 15,5 ± 3 | 16 ± 3 | 15 ± 3 | 0.092 |
| RVAC (%) | 40 ± 5 | 39 ± 6 | 41 ± 4 | 0.147 |
| CMR findings | n = 32 | n = 13 | n = 19 | |
| LVEDVi (mL/m2) | 89 ± 17 | 93 ± 19 | 88 ± 14 | 0.377 |
| LVESVi (mL/m2) | 53 ± 8 | 45 ± 16 | 42 ± 6 | 0.734 |
| LVEF (%) | 52 ± 8 | 53 ± 9,8 | 53 ± 7 | 0.827 |
| LV WMA | 17 (49%) | 10 (63%) | 7 (37%) | 0.181 |
| CMR RVEDVi (mL/m2) | 77 ± 15 | 74 ± 14 | 79 ± 16 | 0.472 |
| CMR RVEF (%) | 60 ± 9 | 55 ± 6 | 58 ± 11 | 0.384 |
| WMA RV | 13 (37%) | 6 (46%) | 7 (37%) | 0.720 |
| FAT LV | 12 (38%) | 5 (39%) | 7 (37%) | 1.000 |
| LGE LV | 32 (100%) | 13 (100%) | 19 (100%) | 1.000 |
| LGE LV > 2 segments | 25 (78%) | 10 (77%) | 15 (79%) | 1.000 |
| FAT RV | 5 (16%) | 4 (31%) | 1 (5%) | 0.132 |
| LGE RV | 2 (6%) | 1 (8%) | 1 (5%) | 0.780 |
| LGE RV > 2 segments | 1 (3%) | 1 (8%) | 0 (0%) | 0.406 |
CMR: cardiac magnetic resonance; LV: left ventricular; RV: right ventricular; LVEDVi: indexed LV end-diastolic volume; LVESVi: indexed LV end-systolic volume; LVEF: LV ejection fraction; RVA: RV area; RVAC: RV area change; WMA: wall motion abnormalities; and LGE: late enhancement.